TY - JOUR T1 - THE NOVEL MELATONIN AGONIST, AGOMELATINE (S20098), IS AN ANTAGONIST AT 5-HYDROXYTRYPTAMINE2C RECEPTORS, BLOCKADE OF WHICH ENHANCES THE ACTIVITY OF FRONTOCORTICAL DOPAMINERGIC AND ADRENERGIC PATHWAYS JF - Journal of Pharmacology and Experimental Therapeutics JO - J Pharmacol Exp Ther DO - 10.1124/jpet.103.051797 AU - Mark J. Millan AU - Alain Gobert AU - Françoise Lejeune AU - Anne Dekeyne AU - Adrian Newman-Tancredi AU - Valérie Pasteau AU - Jean-Michel Rivet AU - Didier Cussac Y1 - 2003/05/15 UR - http://jpet.aspetjournals.org/content/early/2003/05/15/jpet.103.051797.abstract N2 - 300 Multiple ChoicesThis is a pdf-only article and there is no markup to show you.full-text.pdf ER -